BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12241544)

  • 1. Lipolysis generates platelet dysfunction after in vivo heparin administration.
    Muriithi EW; Belcher PR; Day SP; Chaudhry MA; Caslake MJ; Wheatley DJ
    Clin Sci (Lond); 2002 Oct; 103(4):433-40. PubMed ID: 12241544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin, platelet aggregation, neutrophils, and cardiopulmonary bypass.
    Belcher PR; Muriithi EW; Milne EM; Wanikiat P; Wheatley DJ; Armstrong RA
    Thromb Res; 2000 May; 98(4):249-56. PubMed ID: 10822071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin-induced platelet dysfunction and cardiopulmonary bypass.
    Muriithi EW; Belcher PR; Day SP; Menys VC; Wheatley DJ
    Ann Thorac Surg; 2000 Jun; 69(6):1827-32. PubMed ID: 10892931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macroaggregation of platelets in plasma, as distinct from microaggregation in whole blood (and plasma), as determined using optical aggregometry and platelet counting respectively, is specifically impaired following cardiopulmonary bypass in man.
    Menys VC; Belcher PR; Noble MI; Evans RD; Drossos GE; Pillai R; Westaby S
    Thromb Haemost; 1994 Oct; 72(4):511-8. PubMed ID: 7533335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous blood transfusion for cardiopulmonary bypass: effects of storage conditions on platelet function.
    Ramnarine IR; Higgins MJ; McGarrity A; Mahmood Z; Wheatley DJ; Belcher PR
    J Cardiothorac Vasc Anesth; 2006 Aug; 20(4):541-7. PubMed ID: 16884986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of ex vivo anticoagulants on whole blood platelet aggregation.
    Kalb ML; Potura L; Scharbert G; Kozek-Langenecker SA
    Platelets; 2009 Feb; 20(1):7-11. PubMed ID: 19172515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of different anticoagulants on platelet aggregation in whole blood; a comparison between citrate, low molecular mass heparin and hirudin.
    Wallén NH; Ladjevardi M; Albert J; Bröijersén A
    Thromb Res; 1997 Jul; 87(1):151-7. PubMed ID: 9253810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative detection of platelet aggregates in whole blood without fixation.
    Muriithi EW; Belcher PR; Menys VC; Chaudhry MA; Raco L; Day SP; Wheatley DJ
    Platelets; 2000 Feb; 11(1):33-7. PubMed ID: 10938879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protamine reversal of heparin affects platelet aggregation and activated clotting time after cardiopulmonary bypass.
    Mochizuki T; Olson PJ; Szlam F; Ramsay JG; Levy JH
    Anesth Analg; 1998 Oct; 87(4):781-5. PubMed ID: 9768770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of Multiplate platelet aggregometry using citrate, heparin or hirudin in Rhesus macaques.
    Dugan G; O'Donnell L; Hanbury DB; Cline JM; Caudell DL
    Platelets; 2015; 26(8):730-5. PubMed ID: 25549285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant hirudin as an anticoagulant during cardiac operations: experiments in a pig model.
    Riess FC; Pötzsch B; Behr I; Jäger K; Rössing R; Bleese N; Schaper W; Müller-Berghaus G
    Eur J Cardiothorac Surg; 1997 Apr; 11(4):739-45. PubMed ID: 9151047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of lipoprotein lipase induced cholesterol ester accumulation in human hepatoma HepG2 cells.
    Cianflone K; Avramoglu RK; Sawyez C; Huff MW
    Atherosclerosis; 1996 Feb; 120(1-2):101-14. PubMed ID: 8645351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of heparin-stimulated plasma lipolytic activity on VLDL APO B subclass metabolism in normal subjects.
    Malmström R; Packard CJ; Caslake M; Bedford D; Stewart P; Shepherd J; Taskinen MR
    Atherosclerosis; 1999 Oct; 146(2):381-90. PubMed ID: 10532694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet aggregatory responses to low-dose collagen are maintained in hirudin-anticoagulated whole blood for 24 h when stored at room temperature.
    Belcher PR; Muriithi EW; Day SP; Wheatley DJ
    Platelets; 2001 Feb; 12(1):34-6. PubMed ID: 11281628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein lipase, hepatic lipase and plasma lipolytic activity. Effects of heparin and a low molecular weight heparin fragment (Fragmin).
    Persson E
    Acta Med Scand Suppl; 1988; 724():1-56. PubMed ID: 2843005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin and low molecular weight heparin but not hirudin stimulate platelet aggregation in whole blood from acetylsalicylic acid treated healthy volunteers.
    Chen JH; Karlberg KE; Sylvén C
    Thromb Res; 1991 Aug; 63(3):319-29. PubMed ID: 1659747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase in lipolysis and decrease in plasma-heparin lipoprotein lipase activity and alpha 1 lipoprotein level after aminophylline in man.
    Zanaboni L; Bonfiglioli D; Sommariva D; D'Adda D; Fasoli A
    Eur J Clin Pharmacol; 1981; 19(5):349-51. PubMed ID: 7238563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin enhances platelet aggregation irrespective of anticoagulation with citrate or with hirudin.
    Chen J; Karlberg KE; Sylvén C
    Thromb Res; 1992 Jul; 67(2):253-62. PubMed ID: 1440527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrolysis of bovine and caprine milk fat globules by lipoprotein lipase. Effects of heparin and of skim milk on lipase distribution and on lipolysis.
    Sundheim G; Bengtsson-Olivecrona G
    J Dairy Sci; 1987 Dec; 70(12):2467-75. PubMed ID: 3448103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anesthetics and anticoagulants used in the preparation of rat platelet-rich-plasma alter rat platelet aggregation.
    Dwyer SD; Meyers KM
    Thromb Res; 1986 Apr; 42(2):139-51. PubMed ID: 3087006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.